RAMM Pharma Corp.
RAMM
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -559.20K | -5.16M | -380.70K | -145.90K | -719.50K |
| Total Depreciation and Amortization | 89.50K | 85.40K | 109.70K | 156.40K | 169.80K |
| Total Amortization of Deferred Charges | 500.00 | 400.00 | 400.00 | 400.00 | -- |
| Total Other Non-Cash Items | -284.80K | 3.72M | -5.20K | -479.70K | -16.00K |
| Change in Net Operating Assets | 506.20K | 1.29M | 101.50K | 133.90K | 382.20K |
| Cash from Operations | -247.90K | -60.40K | -174.30K | -334.90K | -183.50K |
| Capital Expenditure | -- | -- | -- | 17.60K | -17.60K |
| Sale of Property, Plant, and Equipment | 404.60K | 269.80K | 36.70K | 556.40K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 404.60K | 269.80K | 36.70K | 574.00K | -17.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.70K | -17.10K | -17.00K | -48.40K | -63.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -400.00 | -8.20K | -- | -- |
| Cash from Financing | -13.80K | -12.70K | -18.30K | -34.10K | -44.30K |
| Foreign Exchange rate Adjustments | -9.10K | 1.10K | -1.40K | -18.70K | 10.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 133.80K | 197.80K | -157.20K | 186.40K | -234.80K |